Technology

ZT Baseball National Prospects Team Wins Two National Titles in Summer 2024

Published

2 years ago

July 5, 2024

HOUSTON, July 5, 2024 /PRNewswire/ — In an extraordinary display of talent and determination, the ZT Baseball National Prospects Team clinched two prestigious national titles this summer. This remarkable achievement has not only solidified its reputation as a powerhouse in youth baseball, but has also showcased the depth of talent and commitment within the organization.

A Season of Excellence
The journey to these national titles began early in the season, with the team demonstrating consistent excellence in regional tournaments and showcases. Under the expert guidance of head coach Carlos Avila, the players honed their skills, focused on teamwork and embraced a winning mindset. Their efforts resulted in a summer filled with thrilling victories and memorable performances.

ZT Corporate Gives Back
The team’s accomplishments are the culmination of ZT Corporate’s desire to give back to the community. Established in 1997, ZT Corporate, the parent company of Altus Community Healthcare, is a private equity firm with a dynamic portfolio in healthcare services and automotive dealerships. Driven by his love for America’s pastime, ZT Corporate CEO Taseer Badar founded ZT Baseball in 2017.

ZT Baseball provides opportunities and exposure for young players, while competing at the highest level, instilling discipline, teamwork, sportsmanship and honesty. The coaches focus on developing the skills needed for college placement, while creating an affordable and economical option for players and their families. The organization has over 100 teams and 130 coaches throughout the nation.

The First Title:
Emphasizing a high-energy, team-oriented approach, the ZT National Prospects team won the 13U National Championship crown in June, defeating 15 other stellar squads from across the country competing in Cary, North Carolina. ZT National dominated the tournament, with Nathan Handley-White, Tre’ Lawrence, Brody Taylor and Nateo “Monster” Victorio earning All-Tournament recognition for outstanding performance.

The Second Title: 13U National Invitational Championship
Within 24 hours of celebrating its championship in North Carolina, the ZT team joined the best 36 teams in the country to compete for the 2024 13U National Invitational Championship in Chesterfield, Missouri. Victorio’s thrilling walk-off hit with the bases loaded and one out in the bottom of the final inning gave the ZT National Prospects 13U National team a hard-fought championship. They defeated a solid Texas 12 squad that advanced through the winners’ bracket. The resilient ZT team grinded it out, advancing through the consolation bracket of the double-elimination tournament – winning six games in two days in the 100-degree heat of late June to earn its shot at a second national title in 2024.

Coach Avila praised the effort and dedication of his players as the heart and soul of the team came together in the clutch. “Honestly, this championship is a credit to the boys. They did it. I told them if they wanted it, go get it. And they wanted it. Now, we’re national champions. I’m so proud of each and every one of them.”

“We’re very happy,” Badar said following the six-day tournament and big win. “We had some Super Bowl hangover, after winning in Cary. Everyone was a little tired, but the kids collected themselves and pushed through. From the beginning, we set out to help kids, and I think we helped a lot of them.”

A Bright Future Ahead
Winning two national titles in one summer is a testament to the talent and hard work of the players, coaches and support staff of the ZT Baseball National Prospects Team. These victories have not only brought pride to the organization, but have also highlighted the potential of these young athletes.

The team’s success has sparked excitement within the baseball community, with many scouts and college recruiters taking notice of the talent within the ZT program. For the players, these achievements are just the beginning. As they continue to develop their skills and gain valuable experience, the future looks incredibly bright.

Importance of Community Support
All season long, the community rallied behind the team with unwavering support for the players and coaches. In assessing the season, Coach Avila emphasized how important this was to the team. “Our success is a reflection of the support we’ve received from our families, friends and fans,” he said. “We couldn’t have achieved this without them.”

The ZT Baseball National Prospects Team’s summer of 2024 will be remembered as a season of triumph and inspiration. The journey to winning two national titles is a story of talent, hard work and the unbreakable spirit of young athletes striving for greatness. As they look ahead to future seasons, the team remains committed to excellence and is poised to continue its winning legacy.

ABOUT ZT CORPORATE: ZT Corporate is a private equity firm specializing in healthcare and automotive investments, known for its strategic vision and commitment to excellence. With a portfolio that spans some of the most innovative and impactful companies in the sectors it serves, ZT Corporate is dedicated to creating value for its investors and stakeholders through a disciplined investment approach and a strong emphasis on operational excellence.

CONTACT:
Kenneth Klos at 214-796-8406
kklos@altushealthsystem.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/zt-baseball-national-prospects-team-wins-two-national-titles-in-summer-2024-302190066.html

SOURCE ZT Baseball

Technology

MATSON ANNOUNCES ADDITION OF 3 MILLION SHARES TO EXISTING SHARE REPURCHASE PROGRAM AND QUARTERLY DIVIDEND OF $0.36 PER SHARE

Published

27 minutes ago

April 23, 2026

HONOLULU, April 23, 2026 /PRNewswire/ — The Board of Directors of Matson, Inc. (NYSE: MATX), a leading U.S. carrier in the Pacific, approved adding three million shares to its existing share repurchase program and extending the program to December 31, 2029. As of April 23, 2026, the existing share repurchase program had approximately 0.7 million shares remaining. The Board also declared a second quarter dividend of $0.36 per common share. The dividend will be paid on June 4, 2026 to all shareholders of record as of the close of business on May 7, 2026.

“We are pleased to announce an additional three million shares to our existing share repurchase program,” said Matt Cox, Matson’s Chairman and Chief Executive Officer. “Since we commenced our share repurchase program in August 2021, we have repurchased approximately 14.3 million shares, or approximately 33% of the then outstanding shares, for a total cost of $1.3 billion. Going forward, we will continue to be both disciplined and opportunistic in our capital allocation, and we remain committed to returning excess cash to shareholders to create additional shareholder value over the long-term.”

Shares will be repurchased in the open market from time to time at the Company’s discretion, based on ongoing assessments of the capital needs of the business, the market price of its common shares and general market conditions. The Company may enter into Rule 10b5-1 plans to facilitate purchases under the program. The repurchase program may be suspended or discontinued at any time.

About the Company

Founded in 1882, Matson (NYSE: MATX) is a leading provider of ocean transportation and logistics services. Matson provides a vital lifeline of ocean freight transportation services to the domestic non-contiguous economies of Hawaii, Alaska, and Guam, and to other island economies in Micronesia. Matson also operates premium, expedited services from China to Long Beach, California, which includes cargo from other Asia origins, provides services to Okinawa, Japan and various islands in the South Pacific, and operates an international export service from Alaska to Asia. The Company’s fleet of owned and chartered vessels includes containerships, combination container and roll-on/roll-off ships and barges. Matson Logistics, established in 1987, extends the geographic reach of Matson’s transportation network throughout North America and Asia. Its integrated logistics services include rail intermodal, highway brokerage, warehousing, freight consolidation, supply chain management, and freight forwarding to Alaska. Additional information about the Company is available at www.matson.com.

Forward Looking Statements

Statements in this news release that are not historical facts are “forward-looking statements,” within the meaning of the Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties that could cause actual results to differ materially from those contemplated by the relevant forward-looking statement, including but not limited to, statements about capital allocation plans, the timing, manner and volume of repurchases of common shares pursuant to the repurchase program, and use of excess cash. These forward-looking statements are not guarantees of future performance. This release should be read in conjunction with our Annual Report on Form 10-K and our other filings with the SEC through the date of this release, which identify important factors that could affect the forward-looking statements in this release. We do not undertake any obligation to update our forward-looking statements.

View original content to download multimedia:https://www.prnewswire.com/news-releases/matson-announces-addition-of-3-million-shares-to-existing-share-repurchase-program-and-quarterly-dividend-of-0-36-per-share-302752377.html

SOURCE Matson, Inc.

Technology

Accord Specialty Pharmacy Named Finalist in MMIT’s 11th Annual Retail Specialty Pharmacy Patient Choice Awards

Published

1 hour ago

April 23, 2026

ORLANDO, Fla., April 23, 2026 /PRNewswire/ — Accord Specialty Pharmacy, an independent specialty pharmacy serving patients across multiple states, has been named a finalist in the MMIT Patient Choice Awards, a recognition based on patient-reported satisfaction and experience.

Accord was selected as the only independent pharmacy among finalists in its category, alongside national pharmacy organizations such as Walgreens Specialty Pharmacy and Walmart Specialty Pharmacy. This distinction highlights the company’s commitment to delivering personalized, high-touch care for patients managing complex and chronic conditions.

The MMIT Patient Choice Awards recognize specialty pharmacies that demonstrate excellence in patient satisfaction, service quality, and overall care experience. Finalists are determined based on direct patient feedback, making the recognition a meaningful reflection of the trust patients place in their pharmacy providers.

“Being recognized alongside national organizations and as the only independent finalist validates our belief that personalized, patient-centered care drives better outcomes. We are building a model that combines clinical depth, national reach, and operational flexibility to better serve patients, providers, and partners.” said AJ Patel, Founder and Pharmacy Manager of Accord Specialty Pharmacy.

Accord Specialty Pharmacy supports patients across complex specialty categories, including oncology, rare disease, and infusion, through a clinically driven, high-touch care model designed to improve access, adherence, and outcomes. The company’s approach emphasizes personalized support, responsive care coordination, and strong clinical engagement to help patients navigate complex therapies more effectively. With a growing national footprint and multi-state licensure, Accord is positioned to support patients, providers, and partners across diverse markets.

For more information, visit MMIT Announces Finalists of the 11th Specialty Pharmacy Patient Choice Awards – MMITNetwork.

About Accord Specialty Pharmacy:

Accord Specialty Pharmacy is an ACHC-accredited, multi-state licensed independent specialty pharmacy located in Central Florida, dedicated to delivering high-quality, patient-centered care for individuals managing complex and chronic conditions. Through personalized support, clinical expertise, and a high-touch approach, Accord helps patients navigate every step of their treatment journey. Learn more at www.accordspecialty.com.

CONTACT: contact@accordspecialty.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accord-specialty-pharmacy-named-finalist-in-mmits-11th-annual-retail-specialty-pharmacy-patient-choice-awards-302752327.html

SOURCE Accord Specialty

Technology

HAIVISION ANNOUNCES VOTING RESULTS FROM 2026 ANNUAL MEETING OF SHAREHOLDERS

Published

1 hour ago

April 23, 2026

MONTRÉAL, April 23, 2026 /CNW/ – Haivision Systems Inc. (“Haivision” or the “Company”) (TSX: HAI) is pleased to announce the voting results from its annual meeting of shareholders held today in a virtual format.

A total of approximately 45.97 % of the issued and outstanding common shares of Haivision were represented at the meeting.

Election of Directors

Each of the six nominated directors of Haivision was elected as director of the Company with the following results:

Director

Votes
For

% Votes
For

Votes
Against

% Votes
Against

Miroslav Wicha

11,110,245

99.26 %

82,583

0.74 %

Harvey Bienenstock

11,155,137

99.66 %

37,691

0.34 %

Robin M. Rush

11,121,855

99.37 %

70,973

0.63 %

Neil Hindle

10,794,005

96.44 %

398,823

3.56 %

Julie Tremblay

10,941,969

97.76 %

250,859

2.24 %

Lee K. Levy II

9,084,418

81.16 %

2,108,410

18.84 %

2. Appointment of Auditors

Deloitte LLP were reappointed auditors of the Company for the ensuing year with 12,492,582 (98.84%) votes cast in favour and 146,406 (1.16%) votes withheld.

3. Approval of the Unallocated Awards under the Company’s Equity Incentive Plan

The Company’s unallocated awards were approved with 8,710,347 (77.82%) votes cast in favour and 2,482,481 (22.18%) votes cast against.

4. Reapproval of Company’s Shareholder Rights Plan

The Company’s shareholder rights plan was approved with 10,572,490 (94.46%) votes cast in favour and 620,338 (5.54%) votes cast against.

Final voting results on all matters voted on at the meeting will be filed under Haivision’s profile on SEDAR+ at www.sedarplus.ca.

About Haivision

Haivision is a leading global provider of mission-critical, real-time video streaming and visual collaboration solutions. Our connected cloud and intelligent edge technologies enable organizations globally to engage audiences, enhance collaboration, and support decision making. We provide high quality, low latency, secure, and reliable live video at a global scale. Haivision open sourced its award-winning SRT low latency video streaming protocol and founded the SRT Alliance to support its adoption. Awarded four Emmys® for Technology and Engineering from the National Academy of Television Arts and Sciences, Haivision continues to fuel the future of IP video transformation. Founded in 2004, Haivision is headquartered in Montreal and Chicago with offices, sales, and support located throughout the Americas, Europe, and Asia. Learn more at haivision.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/haivision-announces-voting-results-from-2026-annual-meeting-of-shareholders-302752318.html

SOURCE Haivision Systems Inc.